Title : Modulation of multidrug resistance p-glycoprotein activity by flavonoids and honokiol in human doxorubicin- resistant sarcoma cells (MES-SA/DX-5): implications for natural sedatives as chemosensitizing agents in cancer therapy.

Pub. Date : 2010 Apr-Jun

PMID : 20487633






4 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Multidrug resistance (MDR) in cancer cells is often caused by the high expression of the plasma membrane drug transporter P-glycoprotein (Pgp) associated with an elevated intracellular glutathione (GSH) content in various human tumors. Glutathione ATP binding cassette subfamily B member 1 Homo sapiens
2 Multidrug resistance (MDR) in cancer cells is often caused by the high expression of the plasma membrane drug transporter P-glycoprotein (Pgp) associated with an elevated intracellular glutathione (GSH) content in various human tumors. Glutathione ATP binding cassette subfamily B member 1 Homo sapiens
3 Multidrug resistance (MDR) in cancer cells is often caused by the high expression of the plasma membrane drug transporter P-glycoprotein (Pgp) associated with an elevated intracellular glutathione (GSH) content in various human tumors. Glutathione ATP binding cassette subfamily B member 1 Homo sapiens
4 Multidrug resistance (MDR) in cancer cells is often caused by the high expression of the plasma membrane drug transporter P-glycoprotein (Pgp) associated with an elevated intracellular glutathione (GSH) content in various human tumors. Glutathione ATP binding cassette subfamily B member 1 Homo sapiens